Universe Pharmaceuticals Inc
3 hedge funds and large institutions have $332K invested in Universe Pharmaceuticals Inc in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$160K |
| 2 |
Millennium Management
New York
|
+$144K |
| 3 |
Jane Street
New York
|
+$63.8K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $140K | +$160K | +10 | New |
|
|
2
Millennium Management
New York
| $128K | +$144K | +9 | New |
|
|
3
Jane Street
New York
| $61K | +$63.8K | +4 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
UPC Hedge Fund Activity: Q1 2021 in Review
3 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q1 2021, worth a combined $332K.
Buyers outnumbered sellers: 3 funds opened new UPC positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $160K.
- 3 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $332K of Universe Pharmaceuticals Inc stock for Q1 2021.
- 3 funds opened new Universe Pharmaceuticals Inc positions in Q1 2021 and 0 closed out, a net change of +3 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q1 2021 was UBS Group, an estimated $160K added.
Based on aggregated 13F filings for Q1 2021.